UAB CSO PHARMA BALTIC EESTI FILIAAL
Date of report 10.01.2025
UAB CSO PHARMA BALTIC EESTI FILIAAL
Former names
- UAB "PHARMEXX BALTIC" Eesti filiaal
start | end |
---|---|
25.05.2011 | - |
keywords
- muud äritegevuse abiteenused
UAB CSO PHARMA BALTIC EESTI FILIAAL
Scores and ratings
Reputation score
Credit Score
Open the reports you want to print
Employees and salaries
UAB CSO PHARMA BALTIC EESTI FILIAAL
Employee taxes and performance analysisQuarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
---|---|---|---|---|
2024 III | ...... | ...... | ...... | ...... |
2024 II | ...... | ...... | ...... | ...... |
2024 I | ...... | ...... | ...... | ...... |
2023 IV | ...... | ...... | ...... | ...... |
2023 III | ...... | ...... | ...... | ...... |
2023 II | ...... | ...... | ...... | ...... |
2023 I | ...... | ...... | ...... | ...... |
2022 IV | ...... | ...... | ...... | ...... |
2022 III | ...... | ...... | ...... | ...... |
2022 II | ...... | ...... | ...... | ...... |
2022 I | ...... | ...... | ...... | ...... |
2021 IV | ...... | ...... | ...... | ...... |
2021 III | ...... | ...... | ...... | ...... |
2021 II | ...... | ...... | ...... | ...... |
2021 I | ...... | ...... | ...... | ...... |
2020 IV | ...... | ...... | ...... | ...... |
2020 III | ...... | ...... | ...... | ...... |
2020 II | ...... | ...... | ...... | ...... |
2020 I | ...... | ...... | ...... | ...... |
2019 IV | ...... | ...... | ...... | ...... |
2019 III | ...... | ...... | ...... | ...... |
2019 II | ...... | ...... | ...... | ...... |
2019 I | ...... | ...... | ...... | ...... |
2018 IV | ...... | ...... | ...... | ...... |
2018 III | ...... | ...... | ...... | ...... |
2018 II | ...... | ...... | ...... | ...... |
2018 I | ...... | ...... | ...... | ...... |
2017 IV | ...... | ...... | ...... | ...... |
2017 III | ...... | ...... | ...... | ...... |
2017 II | ...... | ...... | ...... | ...... |
2017 I | ...... | ...... | ...... | ...... |
2016 IV | ...... | ...... | ...... | ...... |
2016 III | ...... | ...... | ...... | ...... |
2016 II | ...... | ...... | ...... | ...... |
2016 I | ...... | ...... | ...... | ...... |
2015 IV | ...... | ...... | ...... | ...... |
2015 III | ...... | ...... | ...... | ...... |
2015 II | ...... | ...... | ...... | ...... |
2015 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
UAB CSO PHARMA BALTIC EESTI FILIAAL
Decision-makersFormer decision-makers
......
Credit Score: Trustworthy
Reputation score: 500
Date of birth: ......
Active relations 1
1 follower
......
Credit Score: Trustworthy
Reputation score: 500
Date of birth: ......
Active relations 1
1 follower
UAB CSO PHARMA BALTIC EESTI FILIAAL
Former decision-makers......
Credit Score: Trustworthy
Reputation score: 310
Date of birth: ......
Active relations 1
2 followers
UAB CSO PHARMA BALTIC EESTI FILIAAL
History of right of representationFinances and assets
UAB CSO PHARMA BALTIC EESTI FILIAAL ...
GoodwillUAB CSO PHARMA BALTIC EESTI FILIAAL
Taxes paid and estimated average salariesUAB CSO PHARMA BALTIC EESTI FILIAAL
Quarterly indicatorsQuarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
---|---|---|---|---|---|---|---|
2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
2018 III | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
2018 II | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
2018 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
2017 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
2017 III | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
2017 II | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
2017 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
2016 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
2016 III | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
2016 II | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
2016 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
2015 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
2015 III | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
2015 II | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
2015 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
UAB CSO PHARMA BALTIC EESTI FILIAAL ...
Sales revenue by countryUAB CSO PHARMA BALTIC EESTI FILIAAL ...
Financial indicators and prognosisUAB CSO PHARMA BALTIC EESTI FILIAAL ...
Financial raiting: "SATISFACTORY" (2024 prognosis)UAB CSO PHARMA BALTIC EESTI FILIAAL
Annual reportsYear | Period | Submitted | Report PDF |
---|---|---|---|
2023 | 01.01.2023–31.12.2023 | 28.06.2024 | ...... |
2022 | 01.01.2022–31.12.2022 | 15.08.2023 | ...... |
2021 | 01.01.2021–31.12.2021 | 26.06.2022 | ...... |
2020 | 01.01.2020–31.12.2020 | 25.06.2021 | ...... |
2019 | 01.01.2019–31.12.2019 | 30.06.2020 | ...... |
2018 | 01.01.2018–31.12.2018 | 03.07.2019 | ...... |
2017 | 01.01.2017–31.12.2017 | 28.06.2018 | ...... |
2016 | 01.01.2016–31.12.2016 | 29.03.2018 | ...... |
2015 | 01.01.2015–31.12.2015 | 29.03.2018 | ...... |
2014 | 01.01.2014–31.12.2014 | 26.06.2015 | ...... |
2013 | 01.01.2013–31.12.2013 | 17.06.2014 | ...... |
2012 | 01.01.2012–31.12.2012 | 11.06.2013 | ...... |
2011 | 01.01.2011–31.12.2011 | 18.06.2012 | ...... |
2010 | 01.01.2010–31.12.2010 | 20.06.2011 | ...... |
2009 | 01.01.2009–31.12.2009 | 12.05.2010 | ...... |
Liabilities and debts
UAB CSO PHARMA BALTIC EESTI FILIAAL
Credit score history and prognosis... €
......
Business risk classes:
Trustworthy NeutralUAB CSO PHARMA BALTIC EESTI FILIAAL
Reports and assets-liabilities overview 10.01.2025UAB CSO PHARMA BALTIC EESTI FILIAAL
Claims historyTotal debt claims: ...... €
...... | ...... |
UAB CSO PHARMA BALTIC EESTI FILIAAL
Income (turnover) and expenditure (taxes paid)Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
---|---|---|---|---|---|
2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 IV | ...... € | ...... € | ...... € | ...... € | ...... |
2018 III | ...... € | ...... € | ...... € | ...... € | ...... |
2018 II | ...... € | ...... € | ...... € | ...... € | ...... |
2018 I | ...... € | ...... € | ...... € | ...... € | ...... |
2017 IV | ...... € | ...... € | ...... € | ...... € | ...... |
2017 III | ...... € | ...... € | ...... € | ...... € | ...... |
2017 II | ...... € | ...... € | ...... € | ...... € | ...... |
2017 I | ...... € | ...... € | ...... € | ...... € | ...... |
2016 IV | ...... € | ...... € | ...... € | ...... € | ...... |
2016 III | ...... € | ...... € | ...... € | ...... € | ...... |
2016 II | ...... € | ...... € | ...... € | ...... € | ...... |
2016 I | ...... € | ...... € | ...... € | ...... € | ...... |
2015 IV | ...... € | ...... € | ...... € | ...... € | ...... |
2015 III | ...... € | ...... € | ...... € | ...... € | ...... |
2015 II | ...... € | ...... € | ...... € | ...... € | ...... |
2015 I | ...... € | ...... € | ...... € | ...... € | ...... |
UAB CSO PHARMA BALTIC EESTI FILIAAL
Bailiff's enforcement proceedings as of 10.01.2025Bailiff's enforcement proceedings MISSING
UAB CSO PHARMA BALTIC EESTI FILIAAL
Regulations of the Payment Order Department as of 10.01.2025Regulations of the Payment Order Department MISSING
UAB CSO PHARMA BALTIC EESTI FILIAAL
Court orders in the register as of 10.01.2025Court order MISSING
UAB CSO PHARMA BALTIC EESTI FILIAAL
Decisions of the Consumer Disputes Committee as of 10.01.2025Consumer disputes MISSING
UAB CSO PHARMA BALTIC EESTI FILIAAL
Court hearings as of 10.01.2025Court hearings MISSING
UAB CSO PHARMA BALTIC EESTI FILIAAL
Rulings as of 10.01.2025Court settlemets MISSING
UAB CSO PHARMA BALTIC EESTI FILIAAL
Notices and announcements as of 10.01.2025Announcements MISSING
Marketing
Business network
UAB CSO PHARMA BALTIC EESTI FILIAAL
Business networkSign in
To expand your connections, log in to the "Networks" environment
Beneficiaries network
UAB CSO PHARMA BALTIC EESTI FILIAAL
Networks - BeneficiariesSign in
To expand your connections, log in to the "Networks" environment
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.